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Covid-19 is rapidly spreading across the world. Many patients will present with a high symptom 
burden, which specialists in palliative care can help manage. Whilst the focus in the media has been 
on mechanical ventilation, increasing numbers of patients will not be suitable for this support due to 
underlying health conditions. Instead, they will require a conservative approach and palliative care 
management.  
After two weeks of caring for inpatients with Covid-19 in a Swiss hospital near Northern Italy, 
treatment plans have changed dramatically. In part, this is due to competition for palliative care 
drugs, which are also used in ICU.  But these changes are also staffing-related. Healthcare workers 
are re-allocated from their own specialities to care for patients with Covid-19 and palliative care is 
new to them. Hence, palliative care assessment and treatment recommendations need to be clear 
and simple to enact, to achieve maximum palliation of symptoms. In addition, our decision-making 
needs to be rapid, as patients are likely to deteriorate quickly. This is emergency palliative care.  In 
this paper, we describe the management plan for three types of patients who are not suitable for 
ventilation: stable, unstable, or at the end of life.  
Categorisation of patients 
We use early warning parameters1 to assess patients with Covid-19, as recommended by the WHO2. 
In addition, patients with a respiration rate of over 25 per minutes and saturations of <88% 
(irrespective of supplemental oxygen therapy), are categorised in the unstable category. As these 
patients deteriorate they will be categorised as end of life.  
Assessment and treatment 
Assessment needs to be concise and quick as patients can deteriorate rapidly. Assessment guidelines 
and treatment plans for patients who are not suitable for life-sustaining therapies need to be shared 
with emergency department staff in particular, as patients present there and palliative care teams 
may not be able to assess in time. Assessments are tailored to the additional time required because 
of limited contact due to infection control nursing requirements and reducing risk of contamination3. 
A Covid-19 specific assessment tool was developed locally, the 3D-Ticino 2019-nCov Score (3D-
TiCoS), which focusses on key symptoms observed in this population, such as dypnoea, distress and 
discomfort (pain). The tool is depicted in Figure 1. Pressure areas are also assessed and the need for 
pressure relieving devices. 
Our medication guidelines are based upon the limitations in resources, particularly the availability of 
midazolam and fentanyl, and are presented for each category of patient in Table 1. Each country will 
have their own preferred route of administration, dose and second line drugs and initially greater 
drug availability. Consider using oral and rectal routes of administration, especially in care homes or 
the community. In all cases, non-essential pharmacological treatments such as statins are 
temporarily stopped in order to prevent potential interactions with experimental COVID-19 disease-
related therapies Stable Patients 
Stable patients, although not suitable for intubation, may still recover. They have a high symptom 
burden including dypnoea, fever, anxiety and shivering. They have their EWS and the 3D-TiCoS 
assessment recorded each nursing shift. Pulse oximetry is more useful than listening to the chest, as 
some non-dyspnoeic patients are still hypoxic and reduces risk of contamination.  Dyspnoea can be 
persistent or intermittent and managed with morphine. 
Fever leads to excessive shivering which causes discomfort. Shivers can be managed with morphine 
and in some cases pethidine has been used.  
Anxiety is high as patients are nursed in isolation and the diagnosis of Covid-19 is received as a 
‘death sentence’. Lorazepam is helpful. Families also have high anxiety as they have minimal contact. 
In some hospitals, one visit is permitted in exceptional situations but it is time consuming to dress 
families in PPE and risks greater contamination. This is difficult if families are in quarantine or unwell 
themselves. . All families are told the patient is ‘sick enough to die’4. Virtual visits have been 
possible. Chaplains take the lead on supporting and informing families. 
Unstable Patients 
A patient may present as unstable or deteriorate and become unstable. Deterioration can be rapid. 
Unstable patients are categorised by an increase in the Early Warning Score (EWS) to over 7 and 
decreased saturation levels below 88% irrespective from supplemental oxygen. These patients are 
not going to recover and need their symptoms managed. Some hydration is given to keep the 
patient comfortable, as well as mouth care. The family needs to be informed of the change in 
situation and it may be possible to arrange a visit. Visits are kept short (about 15 minutes) to reduce 
infection risk5  
End of Life Patients 
These patients have very low saturation levels and are dying. If the patient is unable to communicate 
each shift their restlessness, shivering (hyperthermia), distress, tachycardia and tachypnea are 
assessed (ABDT2 from Italian Agitazione, Brividi (ipertermia), Distress, Tachicardia e Tachipnea). 
Delirium is problematic, especially in combination with dementia, as it increases the contamination 
risk. Patients need sedation but due to limitations in availability of midazolam, creative solutions are 
employed using diazepam, chlorpromazine and levopromazine.  Sedation is also used in the 
presence of haemoptysis, but haemoptysis is only experienced by a minority of patients6. Oxygen 
therapy and other futile treatments are stopped, and comfort care given. Oxygen in this context is 
not helpful to palliate symptoms, as it does not improve hypoxic patients’ comfort, rather opioids 
are more effective7. In addition the mask can cause discomfort especially for patients with delirium. 
If possible a visit from the family is arranged. We would not recommend virtual contact with families 
using Skype or another online system as our experience is at this point as they find it too distressing.  
Conclusion 
Palliative care teams, intensivists and internal medicine specialists all work side by side as palliative 
care is recognised to be at the forefront of this crisis, as it can offer symptom management, support 
to families and spiritual care. Most patients with Covid-19 need palliative care input due to the large 
symptom burden and need for clear and open communication with patients and their families. 
However, due to the potential for rapid deterioration, decisions need to be made quickly, and 
treatment plans need to be clear and simple to follow for the generalist staff caring for them. Care of 
patients with Covid-19 results in huge ethical dilemmas and a toll on the health care teams caring for 
them, not least from shortages in resources, both staffing and pharmaceutical. Palliative care needs 
to adapt to an emergency style of palliative care and be at the forefront to help make the best 
decisions, give care to families and find spiritual support.  
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